University of Pennsylvania
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1740-11-14
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.upenn.edu
Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease
Not Applicable
Active, not recruiting
- Conditions
- Peripheral Artery Disease
- Interventions
- Behavioral: Opt-out
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 1200
- Registration Number
- NCT04536038
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 16
- Registration Number
- NCT04535999
- Locations
- 🇺🇸
Hospital at the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Biocontainment Device for Aerosol Generating Procedures
Not Applicable
Completed
- Conditions
- Protective Device (Physical Object)Droplet SpreadAerosol Disease
- Interventions
- Device: Biocontainment Device For Aerosol Generating Procedures (Biobox)Device: Control for aerosol generating procedures
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 37
- Registration Number
- NCT04532112
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
BAPS in Botswana: The Thotloetso Trial
Not Applicable
Recruiting
- Conditions
- SmokingHIV InfectionsSmoking Cessation
- Interventions
- Behavioral: Cessation Counseling
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 650
- Registration Number
- NCT04532970
- Locations
- 🇧🇼
University of Botswana, Gaborone, Botswana
Genetic Testing in Young Adults With Cancer Study
Not Applicable
Recruiting
- Conditions
- Cancer
- Interventions
- Genetic: Broad gene panel for young adult cancersGenetic: Standard
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 1238
- Registration Number
- NCT04533555
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
User Acceptability of a Device-Based Opioid Overdose Intervention
Completed
- Conditions
- Substance Use DisordersOpioid OverdoseOpioid-use Disorder
- Interventions
- Other: SurveyOther: Interview
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 97
- Registration Number
- NCT04530591
- Locations
- 🇺🇸
Prevention Point Philadelphia, Philadelphia, Pennsylvania, United States
GEnetic Counseling Through Virtual Visits in Parkinson's Disease
Not Applicable
Completed
- Conditions
- Parkinson Disease
- Interventions
- Other: IMAGINE-PDOther: Virtual genetic counselingOther: Telephone genetic counseling
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 370
- Registration Number
- NCT04527146
- Locations
- 🇺🇸
University of Pennsylvania Parkinsons Disease and Movement Disorders Center, Philadelphia, Pennsylvania, United States
Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia
Not Applicable
Completed
- Conditions
- Hypercholesterolemia, Familial
- Interventions
- Other: Standard of CareOther: Genetic Testing
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 240
- Registration Number
- NCT04526457
Improving Inpatient Screening for Hepatitis C
Not Applicable
Completed
- Conditions
- Hepatitis C
- Interventions
- Behavioral: Nudge
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 7634
- Registration Number
- NCT04525690
- Locations
- 🇺🇸
Penn Medicine, Philadelphia, Pennsylvania, United States
FEnofibRate as a Metabolic INtervention for COVID-19
Phase 2
Completed
- Conditions
- Covid19
- Interventions
- Other: Fenofibrate/fenofibric acidOther: PlaceboOther: Usual care
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 701
- Registration Number
- NCT04517396
- Locations
- 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath